Fab fragments from intravenous immunoglobulin prevent hyperacute rejection in the guinea pig-to-rat combination without reducing hemolytic complement activity in rat serum.
Urbani
L
L
Laboratoire de Recherche Chirurgicale, Faculté de Médecine Cochin-Port-Royal, Paris, France.
Cardoso
J
J
Soubrane
O
O
Houssin
D
D
Gautreau
C
C
D000208:Acute Disease; D000818:Animals; D003165:Complement System Proteins / Q000502:physiology*; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000502:physiology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology*; D006461:Hemolysis; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*
D007140:Immunoglobulin Fab Fragments; D016756:Immunoglobulins, Intravenous; D003165:Complement System Proteins